Hôpital Saint-Louis is a hospital in Paris, France. It was built in 1611 by architect Claude Vellefaux at the request of Henry IV of France.

During the past decade, Hopital Saint-Louis conducted 546 clinical trials. In the 10-year time frame, 546 clinical trials started and 164 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 235 clinical trials started and 108 clinical trials were completed. i.e. 46% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Saint-Louis" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 80 trials, followed by "Celgene" with 39 trials sponsored, "The Lymphoma Academic Research Organisation" with 35 trials sponsored, "UNICANCER" with 35 trials sponsored and "Gilead Sciences" with 35 trials sponsored. Other sponsors include 661 different institutions and companies that sponsored additional 255 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Saint-Louis" #1 collaborator was "Merck Sharp & Dohme LLC" with 11 trials as a collaborator, "Ministry of Health, France" with 11 trials as a collaborator, "National Cancer Institute, France" with 11 trials as a collaborator, "Bristol-Myers Squibb" with 10 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 9 trials as a collaborator. Other collaborators include 396 different institutions and companies that were collaborators in the rest 258 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Saint-Louis" are "Acute Myeloid Leukemia" (31 trials), "Breast Cancer" (29 trials), "Myelodysplastic Syndromes" (27 trials), "Multiple Myeloma" (23 trials) and "Melanoma" (19 trials). Many other conditions were trialed in "Hopital Saint-Louis" in a lesser frequency.

Most popular intervention types in "Hopital Saint-Louis" are "Drug" (636 trials), "Other" (109 trials), "Biological" (83 trials), "Procedure" (73 trials) and "Radiation" (34 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (71 trials), "Rituximab" (25 trials), "Cyclophosphamide" (24 trials), "Lenalidomide" (22 trials) and "Azacitidine" (21 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Saint-Louis" are 804 trials for "All" genders, 44 trials for "Female" genders and 30 trials for "Male" genders.

Currently, there are 311 active trials in "Hopital Saint-Louis". 16 are not yet recruiting, 160 are recruiting, 133 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 398 completed trials in Hopital Saint-Louis, 2 suspended trials, and 81 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Saint-Louis, 105 "Phase 1" clinical trials were conducted, 324 "Phase 2" clinical trials and 312 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 77 trials that are defined as “Not Applicable".